Pivot Pharmaceutials Added to CSE25 Index

Cannabis Investing News

Pivot Pharmaceuticals announced it was added to the CSE25 Index, a composite of the 25 largest companies, as measured by market capitalization, listed on the CSE.

Pivot Pharmaceuticals (CSE:PVOT; OTCQB:PVOTF) announced it was added to the CSE25 Index, a composite of the 25 largest companies, as measured by market capitalization, listed on the Canadian Securities Exchange (CSE).

As quoted in the press release:

In addition, the Company is also a constituent of the CSE Composite Index.

“With an impressive pipeline of bio-cannabis products, a strong intellectual property portfolio of formulation and delivery technologies, and the expected addition of ACMPR licensed Agro-Biotech, we are proud to be recognized as leaders on the Canadian Securities Exchange through our inclusion in the CSE25 Index,” said Dr. Patrick Frankham, Chief Executive Officer of Pivot Pharmaceuticals.

Click here to read the full press release.

Source: www.newswire.ca

The Conversation (0)
×